Homepage / Programme Live /

Tirzepatide in youth with type 2 diabetes: a Phase 3, randomised, double-blind, placebo-controlled trial (SURPASS-PEDS) - (P-657)

Talk details

ePosters on Display (no oral presentation)
Novel Advances and Interventions
Tirzepatide in youth with type 2 diabetes: a Phase 3, randomised, double-blind, placebo-controlled trial (SURPASS-PEDS) (P-657)
T. HANNON